.[[Aqemia]].
  , ,
  , ,
  , ,
  , [Aqemia Obsidian](spot://aqemiaobsidian),
  DELS: ,[Aqemia Obsidian](spot://aqemiaobsidian),
  , ,
  , [Aqemia Note](spot://aqemianote), 
  DELS: [Aqemia Note](spot://aqemianote),[Aqemia Obsidian](spot://aqemiaobsidian),[Aqemia Note](spot://aqemianote),[Aqemia Note](spot://aqemianote),

# Top
#### kind: BigAI
#### area: Bio
#### stance: 
## Sections
### Cash
#### cash_trend: upward
#### cash: 
#### cash_available: 190
#### funding: 1.33
### Coolness
#### cool: 
#### cool_why: 
#### cool_mission: 
#### cool_balance: 
#### cool_dan: 
#### mission: 
Our mission is to scale the drug discovery process by leveraging a unique-in-the-world technology combining quantum‑inspired physics and machine learning ￼.
### Deep Learning Projects (DLP)
#### dlp: 
#### dlproj1: Physics-driven generative drug design [https://aqemia.com/]
#### dlproj2: 
Sanofi-Aqemia AI drug discovery partnership [https://www.sanofi.com/en/media-room/press-releases/2021/2021-10-19-07-00-00-2346697]
#### dlproj3: AI-designed preclinical oncology pipeline [*no direct link available*]
### Job Postings
#### job: 
#### job_why: 
#### job_bay: None
#### job_remote: None
### Toxicity
## Misc Fields
#### bam:
#### dlp_:
### funding_justification: Raised ~$32M in Mar 2023 (~23 months ago); base=32/24≈1.33, multiplier=1.0
### proj1: Aqemia Drug Discovery Platform
### justification: 
Aqemia uses a hybrid of generative AI and quantum physics to discover new drug molecules. The French startup’s platform can generate and evaluate huge numbers of compounds, which attracted a multi-year partnership with Sanofi – underscoring how generative AI is expediting pharmatech innovation [oai_citation_attribution:91‡eweek.com](https://www.eweek.com/artificial-intelligence/generative-ai-startups/#:~:text=Aqemia%20uses%20AI%20that%20includes,from%20Aqemia%20on%20the%20horizon) [oai_citation_attribution:92‡eweek.com](https://www.eweek.com/artificial-intelligence/generative-ai-startups/#:~:text=Aqemia)
### proj2: Quantum-informed Generative Models (for molecular design)
### recent_funding: Raised $38M round in Dec 2024 ￼ (total funding >$100M)
### sdfsdfsfsfds: foo
